ProPhase Labs (PRPH) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for ProPhase Labs (PRPH) over the last 16 years, with Q1 2025 value amounting to $8.7 million.
- ProPhase Labs' Net Income towards Common Stockholders rose 128029.69% to $8.7 million in Q1 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 16981.23%. This contributed to the annual value of -$3.8 million for FY2024, which is 85497.51% down from last year.
- According to the latest figures from Q1 2025, ProPhase Labs' Net Income towards Common Stockholders is $8.7 million, which was up 128029.69% from -$786000.0 recorded in Q4 2024.
- In the past 5 years, ProPhase Labs' Net Income towards Common Stockholders ranged from a high of $12.7 million in Q1 2022 and a low of -$8.3 million during Q4 2023
- Its 5-year average for Net Income towards Common Stockholders is $865705.9, with a median of -$741000.0 in 2024.
- The largest annual percentage gain for ProPhase Labs' Net Income towards Common Stockholders in the last 5 years was 2842250.0% (2021), contrasted with its biggest fall of 257080.75% (2021).
- Over the past 5 years, ProPhase Labs' Net Income towards Common Stockholders (Quarter) stood at $11.4 million in 2021, then tumbled by 121.42% to -$2.4 million in 2022, then plummeted by 241.61% to -$8.3 million in 2023, then surged by 90.59% to -$786000.0 in 2024, then soared by 1212.72% to $8.7 million in 2025.
- Its Net Income towards Common Stockholders was $8.7 million in Q1 2025, compared to -$786000.0 in Q4 2024 and -$1.6 million in Q3 2024.